Increasing evidence implicates CEACAM6 as a determinant of malignant cellular behaviour and clinical outcome in a range of human cancers (Hasegawa et al, 1993; Kodera et al, 1993; Scholzel et al, 2000; Jantscheff et al, 2003). Here, CEACAM6 is linked to cancer.